Recently, it has been shown that the loss of Atg7 leads to a stress response only in tumor but not in non-transformed intestinal epithelial cells, potentially opening up a therapeutic window in the context of CRC treatment [13]. This evidence concerns the gene ATG7 and colorectal carcinoma.